Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes

Authors

DOI:

https://doi.org/10.12775/QS.2026.63.73406

Keywords

aesthetic medicine, athlets, body dysmorphic disorder, muscle dysmorphia, anabolic-androgenic steroids, hyaluronic acid, botulinum toxin

Abstract

Background: The convergence of aesthetic medicine and competitive sport has emerged as a domain of growing clinical concern. Image-driven sponsorship, social-media exposure, and the imperative of peak visual presentation may shape demand for minimally invasive procedures among both endurance- and skill-oriented athletes and physique-oriented competitors such as bodybuilders and fitness athletes.

Aim: To synthesise current evidence on metabolic, pharmacokinetic, psychiatric, and psychosocial determinants of aesthetic medicine outcomes in this population and to outline practical recommendations for screening and intervention.

Material and Methods: A narrative review of peer-reviewed literature was undertaken across PubMed, Scopus, and Web of Science, prioritising in vivo studies, systematic reviews, meta-analyses, and guidelines issued by psychiatric and dermatological societies.

Results: Available data suggest that elevated basal metabolic rate, exercise-induced oxidative stress, and tissue hyperperfusion may shorten the effective duration of crosslinked hyaluronic acid fillers and of botulinum neurotoxin in highly active individuals. Concomitant use of anabolic-androgenic steroids, diuretics, and growth-related peptides may modify wound healing, haemostasis, and filler behaviour. Body dysmorphic disorder, muscle dysmorphia, and disordered eating appear over-represented in physique-oriented sport and may underlie compulsive treatment-seeking.

Conclusions: Clinicians treating athletes are encouraged to integrate validated psychometric screening into routine assessment, to anticipate altered pharmacokinetics, and to develop clear psychiatric referral pathways. Prospective trials evaluating filler and neurotoxin durability under sustained physiological stress are warranted.

 

References

1. Cassisi, J. E., Gofman, S., Proctor, M., & Becker, S. (2026). Aesthetic medicine and aesthetic health psychology: Toward an integrative framework for patient-centered care. Journal of Aesthetic Medicine, 2(1), 2. https://doi.org/10.3390/jaestheticmed2010002

2. Małolepsza, A., Kister, K., Laskowski, J., Szabrańska, A., Bronst, P., Czechowska, J., Rosa, L., Zach-Źródlak, M., Rektor, N., & Mazur, M. (2023). Assessment of motivation for using aesthetic medicine procedures and post-treatment satisfaction. Journal of Education, Health and Sport, 45(1), 136–143. https://doi.org/10.12775/JEHS.2023.45.01.009

3. Mancin, P., Gaudenzi, V., Telesca, R., Centofanti, D., Bartoletti, E., & Cerea, S. (2026). Exploring Snapchat dysmorphia, body dysmorphic disorder symptoms, and body trust in patients seeking aesthetic medicine procedures. Aesthetic Surgery Journal, 46(2), 213–221. https://doi.org/10.1093/asj/sjaf185

4. Zaccagni, L., & Gualdi-Russo, E. (2023). The impact of sports involvement on body image perception and ideals: A systematic review and meta-analysis. International Journal of Environmental Research and Public Health, 20(6), 5228. https://doi.org/10.3390/ijerph20065228

5. Burgon, R. H., Beard, J., & Waller, G. (2023). Body image concerns across different sports and sporting levels: A systematic review and meta-analysis. Body Image, 46, 9–31. https://doi.org/10.1016/j.bodyim.2023.04.007

6. Li, Q., Li, H., Zhang, G., Cao, Y., & Li, Y. (2024). Athlete body image and eating disorders: A systematic review of their association and influencing factors. Nutrients, 16(16), 2686. https://doi.org/10.3390/nu16162686

7. Fatt, S. J., George, E., Hay, P., Jeacocke, N., Gotkiewicz, E., & Mitchison, D. (2024). An umbrella review of body image concerns, disordered eating, and eating disorders in elite athletes. Journal of Clinical Medicine, 13(14), 4171. https://doi.org/10.3390/jcm13144171

8. Tod, D., Edwards, C., & Cranswick, I. (2016). Muscle dysmorphia: Current insights. Psychology Research and Behavior Management, 9, 179–188. https://doi.org/10.2147/PRBM.S97404

9. Tavoloni, V., Di Giuseppe, M., Innamorati, M., Mirabella, M., Lingiardi, V., & Muzi, L. (2026). The burden of the perfect frame: A scoping review on personality and muscle dysmorphia. Behavioral Sciences, 16(2), 173. https://doi.org/10.3390/bs16020173

10. Albano, G. D., Amico, F., Cocimano, G., Liberto, A., Maglietta, F., Esposito, M., Rosi, G. L., Di Nunno, N., Salerno, M., & Montana, A. (2021). Adverse effects of anabolic-androgenic steroids: A literature review. Healthcare, 9(1), 97. https://doi.org/10.3390/healthcare9010097

11. Morhy, O. N., Sisnando, A. L., Câmara-Souza, M. B., Carbone, A. C., & De la Torre Canales, G. (2023). High levels of physical activity reduce the esthetic durability of botulinum toxin type A: A controlled single-blind clinical trial. Toxins, 15(7), 463. https://doi.org/10.3390/toxins15070463

12. Veale, D. (2004). Body dysmorphic disorder. Postgraduate Medical Journal, 80(940), 67–71. https://doi.org/10.1136/pmj.2003.015289

13. Pereira, I. N., Chattopadhyay, R., Fitzpatrick, S., Nguyen, S., & Hassan, H. (2023). Evidence-based review: Screening body dysmorphic disorder in aesthetic clinical settings. Journal of Cosmetic Dermatology, 22(7), 1951–1966. https://doi.org/10.1111/jocd.15685

14. Murray, G., Convery, C., Walker, L., & Davies, E. (2021). Guideline for the management of hyaluronic acid filler-induced vascular occlusion. Journal of Clinical and Aesthetic Dermatology, 14(5), E61–E69. PMID: 34188752; PMCID: PMC8211329.

15. Chylińska, N., & Maciejczyk, M. (2025). Hyaluronic acid and skin: Its role in aging and wound-healing processes. Gels, 11(4), 281. https://doi.org/10.3390/gels11040281

16. Abe, M., Masuda, M., Mizukami, Y., Inoue, S., & Mizutani, Y. (2024). Epidermal keratinocytes regulate hyaluronan metabolism via extracellularly secreted hyaluronidase 1 and hyaluronan synthase 3. Journal of Biological Chemistry, 300(7), 107449. https://doi.org/10.1016/j.jbc.2024.107449

17. Wollina, U., & Goldman, A. (2024). Spontaneous and induced degradation of dermal fillers: A review. Journal of Cutaneous and Aesthetic Surgery, 17(4), 273–281. https://doi.org/10.4103/JCAS.JCAS_137_23

18. Master, M., Azizeddin, A., & Master, V. (2024). Hyaluronic acid filler longevity in the mid-face: A review of 33 magnetic resonance imaging studies. Plastic and Reconstructive Surgery – Global Open, 12(7), e5934. https://doi.org/10.1097/GOX.0000000000005934

19. Szwed, M., Szwed, W., Szwed, J., & Miga, N. (2022). HA (hyaluronic acid) fillers in aesthetic medicine – the most common complications. Journal of Education, Health and Sport, 12(8), 722–729. https://doi.org/10.12775/JEHS.2022.12.08.073

20. Kumar, R., & Singh, B. R. (2025). Botulinum toxin: A comprehensive review of its molecular architecture and mechanistic action. International Journal of Molecular Sciences, 26(2), 777. https://doi.org/10.3390/ijms26020777

21. Satriyasa, B. K. (2019). Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: A literature review of clinical use and pharmacological aspect. Clinical, Cosmetic and Investigational Dermatology, 12, 223–228. https://doi.org/10.2147/CCID.S202919

22. Jaremek, A., Kępa, J., Kandefer, N., Wyszkowski, M., Grabarczyk, A., Pawlak, A., Grad, S., Gregorek, M., & Gregorek, P. (2023). The use of botulinum toxin in medicine: Safety and efficacy based on the latest research. Journal of Education, Health and Sport, 44(1), 35–55. https://doi.org/10.12775/JEHS.2023.44.01.003

23. Grunfeld, A., Murray, C. A., & Solish, N. (2009). Botulinum toxin for hyperhidrosis: A review. American Journal of Clinical Dermatology, 10(2), 87–102. https://doi.org/10.2165/00128071-200910020-00002

24. Lowe, N., Naumann, M., & Eadie, N. (2023). Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine, 102(S1), e32764. https://doi.org/10.1097/MD.0000000000032764

25. Coelho, M. S., de Oliveira, J. M. D., Polmann, H., Pauletto, P., Stefani, C. M., Maciel, L. C. D. L., & Canto, G. D. L. (2024). Botulinum toxin for the management of bruxism: An overview of reviews protocol. BMJ Open, 14(8), e082861. https://doi.org/10.1136/bmjopen-2023-082861

26. Ferrillo, M., Sommadossi, E., Raciti, L., Calafiore, D., Mezian, K., Tarantino, V., Vecchio, M., Longo, U. G., Losco, L., & de Sire, A. (2025). The role of botulinum toxin for masseter muscle hypertrophy: A comprehensive review. Toxins, 17(2), 91. https://doi.org/10.3390/toxins17020091

27. Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502–521. https://doi.org/10.1038/bjp.2008.165

28. Furth, G., Marroquin, N. A., Kirk, J., Ajmal, H., Szeto, M. D., Zueger, M., Quinn, A. P., Carboni, A., & Dellavalle, R. P. (2023). Cutaneous manifestations of anabolic-androgenic steroid use in bodybuilders and the dermatologist's role in patient care. JMIR Dermatology, 6, e43020. https://doi.org/10.2196/43020

29. Żywiec, W., Dorota, A., Kozłowski, K., Dorota, M., Milczarek, C., Koval, I., Mariankowska, A., Czyżewski, B., Czyżewska, J., & Maryniak, N. (2025). Impact of anabolic steroids on tendons: A narrative review. Cureus, 17(10), e93649. https://doi.org/10.7759/cureus.93649

30. Biskup, A., Wnęk, A., Smagowska, J., & Kala-Kaziszyn, E. (2026). Keloid formation in athletes: Pathophysiology, biomechanical risk factors, psychosocial burden, and current therapeutic approaches. Quality in Sport, 56, 71628. https://doi.org/10.12775/QS.2026.56.71628

31. Li, Z., Ma, R., Tan, J., Li, C., Xiao, Y., Qiu, X., Jin, S., Ouyang, P., Zhao, Y., Xiang, X., & Wu, W. (2024). Hormonal interventions in skin wounds – a mini review. Molecular Medicine, 30, 217. https://doi.org/10.1186/s10020-024-00978-6

32. Demling, R. H. (2009). Nutrition, anabolism, and the wound healing process: An overview. Eplasty, 9, e9. PMID: 19274069; PMCID: PMC2642618.

33. Santos, B. M., de Souza, J. P. A., Goulart, L. R. P., Petrine, J. C. P., Alves, F. H. F., & Del Bianco-Borges, B. (2024). Impacts of anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives. Saudi Pharmaceutical Journal, 32(12), 102205. https://doi.org/10.1016/j.jsps.2024.102205

34. Garoufalia, Z., Papadopetraki, A., Karatza, E., Vardakostas, D., Philippou, A., Kouraklis, G., & Mantas, D. (2021). Insulin-like growth factor-I and wound healing, a potential answer to non-healing wounds: A systematic review of the literature and future perspectives. Biomedical Reports, 15(2), 66. https://doi.org/10.3892/br.2021.1442

35. Rück, C., Mataix-Cols, D., Feusner, J. D., Shavitt, R. G., Veale, D., Krebs, G., & Fernández de la Cruz, L. (2024). Body dysmorphic disorder. Nature Reviews Disease Primers, 10(1), 92. https://doi.org/10.1038/s41572-024-00577-z

36. Pérez-Buenfil, L. Á., & Morales-Sánchez, M. A. (2025). Prevalence of body dysmorphic disorder: A systematic review and meta-analysis. Journal of Cosmetic Dermatology, 24(4), e70121. https://doi.org/10.1111/jocd.70121

37. Kaleeny, J. D., & Janis, J. E. (2024). Body dysmorphic disorder in aesthetic and reconstructive plastic surgery – A systematic review and meta-analysis. Healthcare, 12(13), 1333. https://doi.org/10.3390/healthcare12131333

38. Higgins, S., & Wysong, A. (2018). Cosmetic surgery and body dysmorphic disorder – An update. International Journal of Women's Dermatology, 4(1), 43–48. https://doi.org/10.1016/j.ijwd.2017.09.007

39. Veale, D. (2004). Advances in a cognitive behavioural model of body dysmorphic disorder. Body Image, 1(1), 113–125. https://doi.org/10.1016/S1740-1445(03)00009-3

40. Pope, H. G., Jr., Gruber, A. J., Choi, P., Olivardia, R., & Phillips, K. A. (1997). Muscle dysmorphia: An underrecognized form of body dysmorphic disorder. Psychosomatics, 38(6), 548–557. https://doi.org/10.1016/S0033-3182(97)71400-2

41. Stranz, R., Maas genannt Bermpohl, F., Bosbach, K., Grocholewski, A., Martin, A., & Hartmann, A. S. (2026). The cross-sectional relationship between body dysmorphic disorder and perfectionism: A meta-analysis. BMC Psychiatry, 26, 338. https://doi.org/10.1186/s12888-026-08044-7

42. Mikulska, J., Lewandowski, M., Kurkiewicz, W., Woźniak, O., Wąsik, J., Gryboś, K., Sepioło, W., Kiełbratowska, J., & Kwiatkowska, Z. (2025). Eating disorders among athletes: Causes, symptoms, and health consequences. Quality in Sport, 41, 60061. https://doi.org/10.12775/QS.2025.41.60061

43. Foster, A. C., Shorter, G. W., & Griffiths, M. D. (2015). Muscle dysmorphia: Could it be classified as an addiction to body image? Journal of Behavioral Addictions, 4(1), 1–5. https://doi.org/10.1556/JBA.3.2014.001

44. Hogea, L., Bernad, B., Marinca, A., Corsaro, L., Costea, I., Ivanovic, N., & Anghel, T. (2026). Psychological disorder and patient satisfaction in aesthetic surgery – A systematic review. Medicina, 62(2), 389. https://doi.org/10.3390/medicina62020389

45. Haines, M., Sanki, A., & Magnusson, M. R. (2026). A national survey of aesthetic plastic surgeons' experience with mandatory body dysmorphic disorder screening in Australia. Aesthetic Surgery Journal Open Forum, ojag014. https://doi.org/10.1093/asjof/ojag014

46. Czernecka, A., Baran, W., Szepietowski, J., & Batycka-Baran, A. (2023). Body Dysmorphic Disorder Questionnaire–Dermatology Version (BDD-DV): Formation and validation of the Polish language version. Postępy Dermatologii i Alergologii, 40(3), 421–426. https://doi.org/10.5114/ada.2023.128974

47. Fletcher, L. (2021). Development of a multiphasic, cryptic screening protocol for body dysmorphic disorder in cosmetic dermatology. Journal of Cosmetic Dermatology, 20(4), 1254–1262. https://doi.org/10.1111/jocd.13885

48. Walczyńska, A., Jaworski, A. P., Drozdowski, P., & Drozdowska, A. (2021). Postrzeganie dysmorfofobii przez pacjentów leczonych w gabinetach chirurgii plastycznej i medycyny estetycznej – badanie kwestionariuszowe [Perception of body dysmorphic disorder by patients treated in plastic surgery and aesthetic medicine clinics – A questionnaire study]. Chirurgia Plastyczna i Oparzenia, 9(3), 57–65. https://doi.org/10.15374/ChPiO2021015

49. Harrison, A., Fernández de la Cruz, L., Enander, J., Radua, J., & Mataix-Cols, D. (2016). Cognitive-behavioral therapy for body dysmorphic disorder: A systematic review and meta-analysis of randomized controlled trials. Clinical Psychology Review, 48, 43–51. https://doi.org/10.1016/j.cpr.2016.05.007

50. Jonathan, G. K., Armstrong, C., Miyares, P., Williams, J., & Wilhelm, S. (2024). Advancing psychosocial treatment for body dysmorphic disorder (BDD): A state-of-the-science review. Behavior Therapy, 55(6), 1249–1288. https://doi.org/10.1016/j.beth.2024.04.002

51. Rafaeli, E., Bernstein, D. P., & Young, J. (2011). Schema therapy: Distinctive features. Routledge.

52. Liu, Y., Lai, L., Wilhelm, S., Phillips, K. A., Guo, Y., Greenberg, J. L., & Ren, Z. (2024). The efficacy of psychological treatments on body dysmorphic disorder: A meta-analysis and trial sequential analysis of randomized controlled trials. Psychological Medicine, 54(15), 4048–4061. https://doi.org/10.1017/S0033291724002733

53. Jung, H. (2020). Hyaluronidase: An overview of its properties, applications, and side effects. Archives of Plastic Surgery, 47(4), 297–300. https://doi.org/10.5999/aps.2020.00752

54. Buhren, B. A., Schrumpf, H., Hoff, N.-P., Bölke, E., Hilton, S., & Gerber, P. A. (2016). Hyaluronidase: From clinical applications to molecular and cellular mechanisms. European Journal of Medical Research, 21, 5. https://doi.org/10.1186/s40001-016-0201-5

55. Currie, E., Granata, B., Goodman, G., Rudd, A., Wallace, K., Rivkin, A., Hart, S., Porter, C. E., Harris, S., Walker, L., Lin, F., Corduff, N., Davies, N., Roberts, S., Clague, M., Callan, P. P., McDonald, C., Magnusson, M., Tsirbas, A., … Welsh, B. (2024). The use of hyaluronidase in aesthetic practice: A comparative study of practitioner usage in elective and emergency situations. Aesthetic Surgery Journal, 44(6), 647–657. https://doi.org/10.1093/asj/sjae009

56. Daminato, E., Bianchini, G., & Causin, V. (2022). New directions in aesthetic medicine: A novel and hybrid filler based on hyaluronic acid and lactose modified chitosan. Gels, 8(5), 326. https://doi.org/10.3390/gels8050326

57. Łopuszyńska, I., Stańczyk, J., Adamowicz, D., Meliksetian, A., Wosińska, A., Pazik, D., Kosecka, K., Cieślik, A., Jargieło, A., & Kosieradzka, K. (2023). Selected aesthetic medicine treatment in patients with autoimmune diseases – a literature review. Journal of Education, Health and Sport, 21(1), 135–151. https://doi.org/10.12775/JEHS.2023.21.01.014

58. Singh, A. R., & Veale, D. (2019). Understanding and treating body dysmorphic disorder. Indian Journal of Psychiatry, 61(Suppl. 1), S131–S135. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_528_18

59. Caponnetto, P., Caramazza, M., Caci, G., Signorelli, M. S., Petralia, A., & Quattropani, M. C. (2024). Body dysmorphic disorder and psychotherapeutic interventions: A systematic literature review. Health Psychology Research, 12, 117649. https://doi.org/10.52965/001c.117649

Quality in Sport

Downloads

Published

2026-07-14

How to Cite

1.
TSUKERMAN, Jarosław, SZYMOCHA, Joanna, PSIUK, Arkadiusz, WOJAS, Aleksandra, HUZARSKA, Karolina, BARANIECKA, Aleksandra and SMĘDOWSKI, Igor. Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes. Quality in Sport. Online. 14 July 2026. Vol. 63, p. 73406. [Accessed 25 July 2026]. DOI 10.12775/QS.2026.63.73406.

Issue

Vol. 63 (2026)

Section

Medical Sciences

License

Copyright (c) 2026 Jarosław Tsukerman, Joanna Szymocha, Arkadiusz Psiuk, Aleksandra Wojas, Karolina Huzarska, Aleksandra Baraniecka, Igor Smędowski

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Stats

Number of views and downloads: 69
Number of citations: 0